Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Liangrong Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5882-0103; OpenAlex author ID A5068511941. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in… Last author DOI 10.3389/fonc.2021.652426↗
  2. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3. Co-author DOI 10.1038/cddis.2017.525↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Li · 1 shared paper, 2021 · strength 0.11
  2. Changli Peng · 1 shared paper, 2021 · strength 0.11
  3. Jingting Jiang · 1 shared paper, 2017 · strength 0.07
  4. Changping Wu · 1 shared paper, 2017 · strength 0.07
  5. Haijiao Yan · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.